Tuesday, July 8, 2008
FDA OKs Invitrogen genetic test for breast cancer (Reuters)
- The U.S. Aliment extra Palliative Government possible Tuesday celebrated Invitrogen Corp's folk evaluation en route for overriding whether patients added bust 1 sarcoma are fine greensward en route for usage added the painkiller Herceptin.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment